Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €17.50 EUR
Change Today +0.32 / 1.86%
Volume 0.0
VIH On Other Exchanges
As of 2:29 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

vib vermoegen ag (VIH) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/24/15 - €17.88
52 Week Low
08/6/14 - €12.66
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for VIB VERMOEGEN AG (VIH)

Related News

No related news articles were found.

vib vermoegen ag (VIH) Related Businessweek News

No Related Businessweek News Found

vib vermoegen ag (VIH) Details

VIB Vermögen AG develops, buys, holds, and manages commercial real estate properties in Germany. As of December 31, 2014, its real estate portfolio consisted of 100 properties with a total rental area of approximately 928,000 square meters comprising logistics properties, industrial buildings, and shopping and specialist market centers, as well as commercial and service centers. The company was founded in 1993 and is based in Neuburg an der Donau, Germany.

37 Employees
Last Reported Date: 04/22/15
Founded in 1993

vib vermoegen ag (VIH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vib vermoegen ag (VIH) Key Developments

VIB Vermoegen AG Announces Consolidated Earnings Results for the Fiscal Year 2014; Provides Earnings Guidance for the Full Year 2015

VIB Vermoegen AG announced consolidated earnings results for the fiscal year 2014. For the period, the company consolidated revenue was up by 7.6 % to EUR 69.9 million compared to EUR 65.0 million a year ago, and total operating revenue increased by 7.3% to EUR 70.5 million compared to EUR 65.7 million a year ago. Earnings before tax (EBT) excluding valuation effects and extraordinary items of EUR 31.2 million were 15.5 % ahead of the previous year's EUR 27.0 million, thereby exceeding the company's forecast of EUR 29.0 million to EUR 30.5 million. Consolidated net income increased to EUR 32.4 million compared to EUR 29.0 million a year ago. Basic NAV per share stood at EUR 14.54 on the reporting date compared to EUR 13.88 a year ago, and diluted NAV per share amounted to EUR 14.52 compared to EUR 13.52 a year ago. The company provided earnings guidance for the full year 2015. For the period, the company anticipated total operating revenue of between EUR 74.0 million and EUR 77.0 million, EBIT between EUR 53.5 million and EUR 56.0 million, and EBT between EUR 33.0 million and EUR 35.0 million.

Sigma-Aldrich and VIB Partner to Provide Translational Research Tools

Sigma-Aldrich Corporation has announced that its research business unit has formed an alliance with VIB for commercialization and supply of new tools and technologies for translational research. Beginning 2015, Sigma-Aldrich and VIB will collaborate to provide the latest emerging tools and technologies that have demonstrated benefit for translational research and solutions to the challenges that scientists face. Utilizing Sigma-Aldrich's leading R&D and manufacturing capabilities, along with its global distribution network, the alliance will help to accelerate and enhance the commercial development and availability of VIB's research tools and technologies for researchers.

VIB Vermoegen AG to Report Fiscal Year 2014 Final Results on Apr 22, 2015

VIB Vermoegen AG announced that they will report fiscal year 2014 final results on Apr 22, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIH:GR €17.50 EUR +0.32

VIH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VIH.
View Industry Companies

Industry Analysis


Industry Average

Valuation VIH Industry Range
Price/Earnings 14.7x
Price/Sales 6.9x
Price/Book 1.2x
Price/Cash Flow 13.9x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIB VERMOEGEN AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at